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Abstract
Background: Accidents caused by Loxosceles spider may cause severe systemic reactions, including acute kidney injury
(AKI). There are few experimental studies assessing Loxosceles venom effects on kidney function in vivo.
Methodology/Principal Findings: In order to test Loxosceles gaucho venom (LV) nephrotoxicity and to assess some of the
possible mechanisms of renal injury, rats were studied up to 60 minutes after LV 0.24 mg/kg or saline IV injection (control).
LV caused a sharp and significant drop in glomerular filtration rate, renal blood flow and urinary output and increased renal
vascular resistance, without changing blood pressure. Venom infusion increased significantly serum creatine kinase and
aspartate aminotransferase. In the LV group renal histology analysis found acute epithelial tubular cells degenerative
changes, presence of cell debris and detached epithelial cells in tubular lumen without glomerular or vascular changes.
Immunohistochemistry disclosed renal deposition of myoglobin and hemoglobin. LV did not cause injury to a suspension of
fresh proximal tubules isolated from rats.
Conclusions/Significance: Loxosceles gaucho venom injection caused early AKI, which occurred without blood pressure
variation. Changes in glomerular function occurred likely due to renal vasoconstriction and rhabdomyolysis. Direct
nephrotoxicity could not be demonstrated in vitro. The development of a consistent model of Loxosceles venom-induced
AKI and a better understanding of the mechanisms involved in the renal injury may allow more efficient ways to prevent or
attenuate the systemic injury after Loxosceles bite.
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Introduction
Loxosceles spiders can be found worldwide in temperate and tropical
regions but their distribution is heavily concentrated in the Western
Hemisphere [1,2]. In fact, in South America, loxoscelism is considered
the most important form of araneism due to its high incidence
and morbidity [1–3]. In Brazil, Loxosceles spiders were responsible
for approximately 7,000 cases of spider envenomation reported to
the Brazilian Ministry of Health in 2006 [Unpublished data.
SINAN-Animais Pec¸onhentos/SVS/MS. http://dtr2004.saude.gov.
br/sinanweb/tabnet/dh?sinan/animaisp/bases/animaisbr.def].
Loxosceles venom is a complex mixture of several proteins including
alkaline phosphatase, hyaluronidase, 5-ribonucleotidase phosphohy-
drolase, sphingomyelinase D, several proteases, esterase and ATPase.
Sphingomyelinase D is considered the most toxic fraction of the
venom, playing a key role in its local and systemic action [1–4]. It
causes neutrophil migration, complement system activation, cytokine
and chemokine release and platelet aggregation [5].
Loxosceles spiders are not aggressive and the bites usually occur
when they are pressed against the body, mainly while the victim is
sleeping or dressing. The accident may cause mild cutaneous
inflammatory reaction or a local injury characterized by pain,
edema and livedo, developing later to dermonecrosis with gra-
vitational spreading [1–3]. In up to 13% of the cases [1], loxo-
scelism can cause a systemic injury, known as viscerocutaneous
loxoscelism (VCL). This form occurs predominantly in children
[6], and patients may develop acute kidney injury (AKI), which is
considered the main cause of death after loxoscelism envenom-
ation [5,7]. VCL is characterized by fever, malaise, weakness,
nausea and vomiting, hemolysis, hematuria, jaundice, thrombo-
cytopenia and disseminated intravascular coagulation. This severe
multisystemic clinical picture can occur as early as 24 hours after
the bite [1–3,7].
AKI has been described in VCL as single case reports [7–11] or
as relatively small series of cases [12–14]. Data on AKI after VCL
are not consistent, even in the same country. Several factors might
www.plosntds.org 1 May 2011 | Volume 5 | Issue 5 | e1182
account for this, including the spider species and the patient age.
In Brazil, 49% of AKI, 45.7% of oliguria and 8.6% of anuria were
found among 35 VCL cases [6]. On the other hand, among 359
cases treated in Butantan Institute, Brazil, 4% developed VCL and
none presented AKI [15]. In Chile, plasma creatinine was assessed
in 26 of 34 VCL cases and was elevated in all, with values ranging
from 4.4 to 6.0 mg/dL [16]. In the USA, AKI was found in 1 of 6
children hospitalized due to VCL [17]. These differences in AKI
frequency can be due to the distribution of different Loxosceles
species through the North and South Americas [5]. In Sa˜o Paulo
the commonest specie is the Loxosceles gaucho but in other regions of
Brazil the Loxosceles intermedia is the most prevalent. The
mechanisms for Loxosceles venom-induced AKI are still elusive
and renal injury has been attributed to hemolysis, rhabdomyolysis,
shock and direct venom nephrotoxicity [1,2,5,11,14,17–19].
Few experimental studies have focused on the action of the
Loxosceles venom in the kidney, and none have performed a
detailed study on renal function and hemodynamics. The aim of
the present study was to assess the nephrotoxicity of Loxosceles
gaucho venom in rats and study some of the mechanisms possibly
involved in the genesis of the renal injury.
Materials and Methods
Ethics Statement
Experiments were done according to the Brazilian law of
protection of animals. The study was approved by the Animal
Experimentation Ethics Committee (CEEA), FAMERP.
Venom
Specimens of L. gaucho were collected in Sa˜o Paulo State. The
spiders were kept in quarantine for one week without food before
venom collection, and venoms were obtained as previously
described [20]. A pool of venom collected from approximately
1,000 L. gaucho spiders was used. The protein content of venom
pool was determined using bicinchoninic acid [21].
In vivo experiments
Animals. Adult male Wistar rats weighing 150 to 270 g were
housed in a temperature- and light-controlled environment. They
received standard diet and were allowed free access to tap water.
Venom infusion. Loxosceles gaucho venom (LV) was diluted in
saline and infused (240 mg/kg) in the jugular vein at the rate of
0.06 mL/min (infusion pump, model 975, Harvard, USA).
Control animals received the same volume of saline. The LV
dose used was selected after pilot experiments beginning with
0.15 mg/kg that was the LD50 for mice after subcutaneous
injection [22].
Glomerular filtration rate (GFR). After anesthesia with
intraperitoneal thiopental (50 mg/kg) tracheostomy was
performed and a polyethylene tube (PE-50) was placed in a
carotid artery. Mean carotid arterial blood pressure (BP) was
continuously measured with an electronic transducer (P23 Db,
Statham Instruments Division, Could Inc., Hato Rey, USA)
connected to a digital polygraph (Blood Pressure Display Unit,
Stoelting, USA) throughout the experiments. PE-50 tubes were
also placed in both jugular veins and a polyethylene tube (PE-90)
was placed and sutured in the bladder. Animals were main-
tained in a stable temperature (36.561uC) by a thermostatically
controlled warming table (Braile Biome´dica, Sa˜o Jose´ do Rio
Preto, Brazil). After surgery, a dose of 1 mL of inulin solution
(300 mg of inulin in 12 mL of saline, Sigma Chemical Co., St.
Louis, MO, USA) was given, followed by an infusion of the same
solution at a rate of 0.06 mL/min (Harvard infusion pump model
975, USA). After a 60 min equilibration time, LV (venom, n = 8)
or saline (control, n = 8) were infused as described above. After a
30 min equilibration time, urine was collected over two periods of
20 min each. A blood sample (0.3 mL) was drawn at the midpoint
of each urine collection and replaced with an equal volume of
saline. Inulin clearance values, expressed as mL/min/100 g body
wt, represent the means of the two clearance periods. Diuresis
(mL/min) was assessed by the weight difference in the collection
vials before and after urine collection.
Renal blood flow (RBF). Anesthesia, tracheostomy and
carotid and jugular surgical preparation were performed as
previously described. After that, a ventral midline incision was
made, exposing the left renal artery, which was dissected and a
suitable probe (R series, 1.5 mm, Transonic Systems, Ithaca, NY,
USA) was placed around it. At this point LV (venom, n = 8) or
saline (control, n = 8) were infused as already described, followed
by maintenance infusion of saline at 0.06 mL/min (infusion pump,
Harvard Apparatus, Holliston, MA, USA).
After a 60 min equilibration time, four ultrasonic RBF
measurements were performed (T 106, Transonic Systems Inc,
Ithaca, NY, USA) during 10 min observation period. RBF
values represent the means of the four measurements. BP was
continuously monitored as previously described. Renal vascular
resistance (RVR) was calculated by the usual formula (BP/RBF).
Hemolysis and rhabdomyolysis evaluation. Anesthesia,
surgical preparation and venom (venom, n = 8) or saline (control,
n = 8) infusion were carried out as previously described. After 60
minutes of equilibration period blood was collected for
measurement of hematocrit (Hct), creatine kinase (CK), serum
aspartate aminotransferase (AST), serum alanine aminotransferase
(ALT) and lactic dehydrogenase (LDH).
Renal histology
The left kidney was collected at the end of GFR measurements
in 6 rats injected with LV and 6 rats injected with saline. Renal
tissue was fixed in 4% buffered formalin and embedded in
paraffin. Horizontal sections 3 to 4 mm thick were stained with
periodic acid-Schiff’s reagent (PAS), hematoxylin-eosin, Masson
trichrome and periodic acid methenamine silver. The tissue was
evaluated by light microscopy by two observers masked to the
treatment. Tubular, vascular and glomerular changes were
Author Summary
Loxosceles (recluse or brown spider) is the most important
spider genus causing human envenomation. In Brazil
Loxosceles spiders were responsible for approximately
7,000 cases of spider envenomation per year. The brown
spider accidents may cause late cutaneous necrosis at the
bite site, intravascular hemolysis, rhabdomyolysis, coagu-
lation system changes and acute kidney injury (AKI). Even
patients with mild cutaneous lesion may develop severe
hemolysis and AKI, which is the main cause of death after
these accidents. The mechanisms causing kidney injury are
poorly understood. In this manuscript we described a
consistent rodent model of Loxosceles gaucho venom-
induced AKI and studied some of the possible mechanisms
of the renal lesion. The results of this research showed that
kidney injury may occur independently of the cutaneous
lesion and without changes in the systemic blood
pressure. Kidney dysfunction occurred likely due to intra-
renal vasoconstriction and rhabdomyolysis, although a
direct toxic effect of the venom on the proximal tubules
cannot be ruled out.
Loxosceles-Venom Induced Acute Kidney Injury
www.plosntds.org 2 May 2011 | Volume 5 | Issue 5 | e1182
evaluated according a 0 to 3 semiquantitative score. In the vessels
and glomeruli, signs of endothelial injury (fibrin thrombi in
glomerular capillary lumina, disruption or reduplication of the
glomerular capillary basement membrane, swollen endothelial
cells and fibrinoid necrosis) were extensively searched.
Immunohistochemistry
Sections from representative formalin-fixed paraffin embedded
samples were stained with monoclonal antibody against hemoglo-
bin and myoglobin, with amplification by streptavidin-peroxidase
method. Briefly, after deparaffinization in xylene and rehydration
in graded ethanol, antigen epitope retrieval was performed using
10 mM citric acid solution, pH 6.0 in a pressure cooker. En-
dogenous peroxidase activity was blocked with 6% hydrogen
peroxide for 20 min.
Primary mouse Polyclonal Rabbit Anti-human Hemoglobin
antibody (code # A0118, DakoCytomation, USA), diluted 1:1000,
and Sheep Anti-human Myoglobin (code # PH 213, The Binding
Site, USA), diluted 1:50, were incubated for 30 min at 37uC
followed by overnight incubation at 4uC, and then by addition of
biotinylated anti-mouse secondary antibody and streptavidin-
horseradish peroxidase (LSAB+, code # k0690, Dako, Carpin-
teria, CA, USA).
Color of reaction product was developed by 3,39-diaminoben-
zidine and H2O2 and counterstaining was performed with Harris
hematoxylin. The primary antibody was omitted for negative
controls and endothelial cells of tonsil were used as positive
control. The immuno-expression of hemoglobin and myoglobin
was evaluated in a semi-quantitative approach. Samples with no
evidence of staining or those with evidence of only focally positive
cells (,1%) were recorded as negative.
In vitro experiments
Proximal tubule injury. Isolation of proximal tubules (PT):
male Wistar rats were anesthetized with sodium thiopental
(40 mg/kg i.p.). PT were isolated by collagenase digestion and
Percoll gradient as previously described [23].
PT toxicity protocol: LV venom concentrations of 3.17 and
6.34 mg/mL were added at baseline to oxygenated PT suspensions
and kept for 60 min.
Cell injury: Cell injury was assessed by LDH release. LDH was
measured after removal of 1 mL sample from tubules suspension
(venom and time control groups) at baseline and after 60 min.
LDH release was calculated by dividing supernate LDH by total
LDH (supernate + pellet) and expressed as a percentage (n = 5).
Analytical methods
Inulin was determined by chemical anthrone method. CK,
AST, ALT and LDH were assessed by colorimetry (Hitachi auto-
analyzer model 917, Japan). Hct was assessed by a microhemat-
ocrit method.
Statistical analysis
Results are presented as mean6 standard error of mean (SEM).
Comparisons were done by two-tail unpaired Student’s t-test or
one-way ANOVA, as appropriate. P values,0.05 were considered
significant.
Results
Renal function and hemodynamics
Loxosceles gaucho venom caused an early and significant de-
crease in GFR and urinary volume. In the same way, venom
caused a sharp and significant decrease in RBF and a significant
RVR increase. These changes occurred without significant
variation in BP. In the control group saline infusion did not
change GFR, RBF and RVR, urinary volume or blood pressure
(see table1).
Direct tubular toxicity
Loxosceles gaucho venom did not cause cellular injury to PT in
both concentrations utilized. After 60 min LDH release was
21.260.4% in control, 22.061.0% in LV 3.17 mg/mL and
22.460.5% in LV 6.34 mg/mL.
Enzymes and hematocrit
Loxosceles gaucho venom induced a statistically significant increase
in serum CK and AST as compared to control group. LDH and
ALT values also increased in the venom group, but the difference
was not statistically significant when compared to saline-infused
rats. Hematocrit values were similar in venom and control groups
(see table 1).
Histology
In the LV group, rats showed flattened epithelium (score
1.360.2), tubule dilatation (score 1.860.3), presence of cell debris
in tubular lumen (score 1.2560.25) presence of detached epithelial
cells in tubular lumen (score 1.260.2) and acute epithelial
degenerative changes (score 1.660.3). In the control group,
animals showed normal renal histology. Endothelial injury was not
found in any animal. All glomerular capillaries showed patent
lumina and preserved endothelial cells.
Immunohistochemistry
The control group showed negative myoglobin immunostaining
in all rats. In the LV group, three animals presented focal myoglo-
bin deposition (1+), one animal disclosed focal and interstitial
myoglobin staining (1+), one animal showed interstitial myoglobin
deposition (2+) and one animal did not present myoglobin at renal
tissue.
In the control group two animals presented focal hemoglobin
staining (1+) and four animals were negative for hemoglobin. In
the LV group, four animals showed focal hemoglobin staining (1+),
Table 1. Renal and systemic parameters after administration
of Loxosceles venom (venom) or saline (control).
Control (n = 8) Venom (n = 8) P
GFR (mL/min/100 g) 0.9260.06a 0.3060.04 p,0.0001
RBF (mL/min) 4.660.3 1.960.2 p,0.0001
RVR (mmHg/mL/min)* 21.462.4 58.6615.0 p,0.005
BP (mmHg) 13265 12664 NS
Diuresis (mL/min) 9.460.3 5.260.6 p,0.0001
CK (IU/L) 598682 13386220 p,0.005
LDH (IU/L) 91614 3236140 NS
ALT (IU/L) 5764 2266128 NS
AST (IU/L) 12164 283666 p,0.005
Hematocrit (%) 4861 4762 NS
aMean 6 SE; GFR: glomerular filtration rate; RBF: renal blood flow; RVR: renal
vascular resistance; BP: blood pressure; CK: creatine kinase; LDH: lactic
dehydrogenase; ALT: alanine amintransferase; AST: aspartate aminotransferase;
*n = 6 for RVR; NS: not statistically significant.
doi:10.1371/journal.pntd.0001182.t001
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one animal showed (3+) of hemoglobin deposition, and one animal
did not present hemoglobin at renal tissue.
These data are represented at Figure 1.
Discussion
An important and novel result from this study is the finding that
Loxosceles gaucho venom may produce renal damage and rhabdomy-
olysis independently from the dermonecrotic injury or to blood
pressure changes. The factors most likely contributing for the
observed renal injury were renal vasoconstriction and myoglobin-
uria. In a consistent way with the available clinical results
[14,16,24,25] and to data originated from experimental studies in
mice [18,19,26], renal histology disclosed acute tubular necrosis.
There was an early and intense RBF decrease and RVR
increase in venom-infused animals. Loxosceles venom may cause
intravascular clotting and consequently tissue ischemia [27,28],
but this phenomenon was not observed in the present study. Other
mechanisms possibly related to LV-induced decrease in RBF are
the venom toxicity to endothelial cells [29], its property to degrade
extracellular matrix molecules acting against basement membrane
structures [30] and its vasoconstrictive activity [5]. Contrasting
with the findings of an experimental model that utilized Loxosceles
intermedia venom [18], no signs of endothelial injury were found in
the present study, in which Loxosceles gaucho venom was used. These
differences might explain the variation in lethality of the venom of
diverse Loxosceles species. In fact, Loxosceles intermedia venom is more
lethal than Loxosceles gaucho venom [31].
Rhabdomyolysis has been sporadically related after human
loxoscelism [7,14,17]. Although only low myotoxicity activity was
reported in experimental studies with LV [31,32], the venom
clearly caused rhabdomyolysis in the current experiment, as
evidenced by significant CK increase and deposition of myoglobin
in renal tissue. It is noteworthy that rhabdomyolysis was caused by
a systemic venom effect, totally independent from local injury,
which actually did not exist in the present model. Rhabdomyolysis
is a well known cause of AKI, causing direct injury to tubule cells
and inducing or enhancing vasoconstriction [33].
Loxosceles envenomation has been associated to hemolysis in
humans [5,7,34]. Although there was no hematocrit decrease in
the venom-infused rats, renal tissue stained positively for
hemoglobin after venom infusion and LDH was three times
higher in the venom as compared to the control group. Even
considering that this difference was not statistically different, it is
possible that some degree of hemolysis had occurred, contributing
for the renal injury genesis.
The early development of renal dysfunction, the low molecular
weight and the cationic charge of the venom components,
facilitating its renal excretion, suggest that LV might have a
potential direct toxic effect on tubule cells. In fact, Luciano et al.
[18] showed L. intermedia venom binding at glomerular and tubule
cells basement membranes of mice with venom-induced AKI.
Considering that this venom is capable to damage the basement
membrane, a direct nephrotoxicity effect may have contributed to
AKI development in these mice. Chaim et al. [19] demonstrated the
deposit and binding of the dermonecrotic fraction of L. intermedia
venom to renal intrinsic structures of mice with LV-induced renal
injury. When the venom was added to a MDCK cell culture, it
deposited in the cells surface and caused cells structural changes,
impaired spreading and cells adhesion and altered cell viability. The
current results are discordant with this previous paper, since
Loxosceles venom did not cause direct toxicity in proximal tubules
suspension. However, there are some possible explanations for this
difference. While Chaim et al. [19], used cultured MDCK cells, we
used fresh prepared proximal tubules suspension from rats. The
spider species utilized were different, L. gaucho in the present
experiment versus L. intermedia in the other cited studies [18,19].
Finally, it is possible that the venom needs plasma components, such
as complement, not present in our experimental preparation, in
order to cause proximal tubule cell toxicity.
There is just another study assessing the effects of Loxosceles
venom in vivo, which was performed in mice [18]. The authors
didnt measure glomerular filtration rate, systemic and renal
hemodynamic were not assessed, neither muscle enzymes
measured. They found blood urea elevation four hours after
intraperitoneal injection of crude L. intermedia venom. There was
no hemolysis and renal histology analysis disclosed glomerular
collapse and loss of vascular integrity and tubule cell injury. In a
subsequent study, the same group demonstrated that the
intraperitoneal injection of the dermonecrotic fraction of the
venom in mice caused nephrotoxicity similar to that seen with the
crude venom [19].
In summary, intravenous injection of Loxosceles gaucho venom
induced a striking acute kidney injury, without dermonecrotic
lesion or variations in systemic blood pressure. The observed renal
changes were associated to impaired renal blood flow and systemic
rhabdomyolysis. Although a direct venom effect on isolated
proximal tubules was not demonstrated, venom direct nephrotox-
icity cannot be totally ruled out.
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